Literature DB >> 28530117

Combined Impact of Smoking and Early-Life Exposures on Adult Lung Function Trajectories.

James P Allinson1, Rebecca Hardy2, Gavin C Donaldson1, Seif O Shaheen3, Diana Kuh2, Jadwiga A Wedzicha1.   

Abstract

RATIONALE: Both adverse early-life exposures and adult smoking can negatively influence adult lung function trajectory, but few studies consider how the impact of early-life exposures may be modified by subsequent smoking.
METHODS: The Medical Research Council National Survey of Health and Development is a nationally representative cohort, initially of 5,362 individuals, followed since enrollment at birth in March 1946. Using data collected prospectively across life and multilevel modeling, we investigated how the relationships between early-life exposures (infant lower respiratory infection, manual social class, home overcrowding, and pollution exposure) and FEV1 and FVC trajectories between ages 43 and 60-64 years were influenced by smoking behavior.
MEASUREMENTS AND MAIN RESULTS: Among 2,172 individuals, there were synergistic interactions of smoking with infant respiratory infection (P = 0.04) and early-life home overcrowding (P = 0.009), for FEV1 at 43 years. Within smoker-stratified models, there were FEV1 deficits among ever-smokers associated with infant lower respiratory infection (-108.2 ml; P = 0.001) and home overcrowding (-89.2 ml; P = 0.002), which were not evident among never-smokers (-15.9 ml; P = 0.69 and -13.7 ml; P = 0.70, respectively). FVC modeling, including 1,960 individuals, yielded similar results. FEV1 decline was greater in smokers (P < 0.001), but there was no effect of any early-life exposure on FEV1 decline. Neither smoking nor early-life exposures were associated with FVC decline.
CONCLUSIONS: Besides accelerating adult FEV1 decline, cigarette smoking also modifies how early-life exposures impact on both midlife FEV1 and FVC. These findings are consistent with smoking impairing pulmonary development during adolescence or early adulthood, thereby preventing catch-up from earlier acquired deficits.

Entities:  

Keywords:  COPD development; childhood respiratory infections; chronic obstructive pulmonary disease; infancy

Mesh:

Substances:

Year:  2017        PMID: 28530117      PMCID: PMC5649988          DOI: 10.1164/rccm.201703-0506OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  41 in total

1.  The life course prospective design: an example of benefits and problems associated with study longevity.

Authors:  M E J Wadsworth; S L Butterworth; R J Hardy; D J Kuh; M Richards; C Langenberg; W S Hilder; M Connor
Journal:  Soc Sci Med       Date:  2003-12       Impact factor: 4.634

2.  Accumulation of factors influencing respiratory illness in members of a national birth cohort and their offspring.

Authors:  S L Mann; M E Wadsworth; J R Colley
Journal:  J Epidemiol Community Health       Date:  1992-06       Impact factor: 3.710

3.  Spirometric reference values from a sample of the general U.S. population.

Authors:  J L Hankinson; J R Odencrantz; K B Fedan
Journal:  Am J Respir Crit Care Med       Date:  1999-01       Impact factor: 21.405

Review 4.  Early-Life Origins of Chronic Obstructive Pulmonary Disease.

Authors:  Fernando D Martinez
Journal:  N Engl J Med       Date:  2016-09-01       Impact factor: 91.245

5.  Respiratory disease in young adults: influence of early childhood lower respiratory tract illness, social class, air pollution, and smoking.

Authors:  J R Colley; J W Douglas; D D Reid
Journal:  Br Med J       Date:  1973-07-28

6.  An overview of obstructive lung diseases.

Authors:  B Burrows
Journal:  Med Clin North Am       Date:  1981-05       Impact factor: 5.456

7.  Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study.

Authors:  Debra A Stern; Wayne J Morgan; Anne L Wright; Stefano Guerra; Fernando D Martinez
Journal:  Lancet       Date:  2007-09-01       Impact factor: 79.321

8.  Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease.

Authors:  D J Barker; K M Godfrey; C Fall; C Osmond; P D Winter; S O Shaheen
Journal:  BMJ       Date:  1991-09-21

9.  A reexamination of risk factors for ventilatory impairment.

Authors:  B Burrows; R J Knudson; M G Cline; M D Lebowitz
Journal:  Am Rev Respir Dis       Date:  1988-10

10.  The relationship of childhood respiratory illness to adult obstructive airway disease.

Authors:  B Burrows; R J Knudson; M D Lebowitz
Journal:  Am Rev Respir Dis       Date:  1977-05
View more
  30 in total

1.  A Genetic Risk Score Associated with Chronic Obstructive Pulmonary Disease Susceptibility and Lung Structure on Computed Tomography.

Authors:  Elizabeth C Oelsner; Victor E Ortega; Benjamin M Smith; Jennifer N Nguyen; Ani W Manichaikul; Eric A Hoffman; Xiuqing Guo; Kent D Taylor; Prescott G Woodruff; David J Couper; Nadia N Hansel; Fernando J Martinez; Robert Paine; Meilan K Han; Christopher Cooper; Mark T Dransfield; Gerard Criner; Jerry A Krishnan; Russell Bowler; Eugene R Bleecker; Stephen Peters; Stephen S Rich; Deborah A Meyers; Jerome I Rotter; R Graham Barr
Journal:  Am J Respir Crit Care Med       Date:  2019-09-15       Impact factor: 21.405

2.  Phenotypes of Recurrent Wheezing in Preschool Children: Identification by Latent Class Analysis and Utility in Prediction of Future Exacerbation.

Authors:  Anne M Fitzpatrick; Leonard B Bacharier; Theresa W Guilbert; Daniel J Jackson; Stanley J Szefler; Avraham Beigelman; Michael D Cabana; Ronina Covar; Fernando Holguin; Robert F Lemanske; Fernando D Martinez; Wayne Morgan; Wanda Phipatanakul; Jacqueline A Pongracic; Robert S Zeiger; David T Mauger
Journal:  J Allergy Clin Immunol Pract       Date:  2018-09-26

3.  Update in Chronic Obstructive Pulmonary Disease 2017.

Authors:  William Z Zhang; Kazunori Gomi; Seyed Babak Mahjour; Fernando J Martinez; Renat Shaykhiev
Journal:  Am J Respir Crit Care Med       Date:  2018-06-15       Impact factor: 21.405

4.  At the Root: Defining and Halting Progression of Early Chronic Obstructive Pulmonary Disease.

Authors:  Fernando J Martinez; MeiLan K Han; James P Allinson; R Graham Barr; Richard C Boucher; Peter M A Calverley; Bartolome R Celli; Stephanie A Christenson; Ronald G Crystal; Malin Fagerås; Christine M Freeman; Lars Groenke; Eric A Hoffman; Mehmet Kesimer; Kostantinos Kostikas; Robert Paine; Shahin Rafii; Stephen I Rennard; Leopoldo N Segal; Renat Shaykhiev; Christopher Stevenson; Ruth Tal-Singer; Jørgen Vestbo; Prescott G Woodruff; Jeffrey L Curtis; Jadwiga A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  2018-06-15       Impact factor: 21.405

Review 5.  Initiating drug therapy in early stage chronic obstructive pulmonary disease: does it impact the course and outcome?

Authors:  Robert M Burkes; Michael B Drummond
Journal:  Curr Opin Pulm Med       Date:  2019-03       Impact factor: 3.155

6.  Harmonization of Respiratory Data From 9 US Population-Based Cohorts: The NHLBI Pooled Cohorts Study.

Authors:  Elizabeth C Oelsner; Pallavi P Balte; Patricia A Cassano; David Couper; Paul L Enright; Aaron R Folsom; John Hankinson; David R Jacobs; Ravi Kalhan; Robert Kaplan; Richard Kronmal; Leslie Lange; Laura R Loehr; Stephanie J London; Ana Navas Acien; Anne B Newman; George T O'Connor; Joseph E Schwartz; Lewis J Smith; Fawn Yeh; Yiyi Zhang; Andrew E Moran; Stanford Mwasongwe; Wendy B White; Sachin Yende; R Graham Barr
Journal:  Am J Epidemiol       Date:  2018-11-01       Impact factor: 4.897

Review 7.  Critical Challenges and Compelling Questions for Chronic Obstructive Pulmonary Disease. Moving the Field Forward: A National Heart, Lung, and Blood Institute Perspective.

Authors:  Lisa Postow
Journal:  Ann Am Thorac Soc       Date:  2018-12

8.  Childhood Origins of Adult Lung Disease as Opportunities for Prevention.

Authors:  Torie Grant; Emily P Brigham; Meredith C McCormack
Journal:  J Allergy Clin Immunol Pract       Date:  2020-03

Review 9.  More to Explore: Further Definition of Risk Factors for COPD - Differential Gender Difference, Modest Elevation in PM2.5, and e-Cigarette Use.

Authors:  Yixuan Zhang; Lu Wang; Gökhan M Mutlu; Hua Cai
Journal:  Front Physiol       Date:  2021-05-05       Impact factor: 4.566

10.  Fetal Programming: Lung Health and Disease.

Authors:  Ozge Yilmaz; Hasan Yuksel; A Sonia Buist
Journal:  Turk Thorac J       Date:  2021-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.